跳至主要内容
临床试验/NCT02961842
NCT02961842已完成不适用

Combined Colloid Preload And Crystalloid Coload Versus Crystalloid Coload During Spinal Anesthesia for Cesarean Delivery

Mansoura University1 个研究点 分布在 1 个国家目标入组 200 人开始时间: 2016年11月20日最近更新:
适应症
干预措施
相关药物

试验速览

阶段
不适用
状态
已完成
入组人数
200
试验地点
1
主要终点
Total ephedrine dose

研究概览

简要总结

The study will compare one technique of fluid administration (combined colloid preload and crystalloid colaod) with another one (crystalloid coload) during elective cesarean delivery performed under spinal anesthesia.

详细描述

This randomized, controlled, double-blind study will be conducted on ASA physical status II parturients with full-term singleton pregnancy undergoing elective cesarean delivery under spinal anesthesia. Participants will receive either 500 mL colloid preload and 500 mL crystalloid coload (Combination group) or 1000 mL crystalloid coload (Coload group). Systolic blood pressure will be recorded every minute and ephedrine will be administered when hypotension occurs according to a predefined protocol. The total ephedrine dose, time to the first ephedrine dose, heart rate, inferior vena cava diameter, nausea/vomiting, and neonatal Apgar scores will be recorded.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
Triple (Participant, Investigator, Outcomes Assessor)

入排标准

年龄范围
19 Years 至 40 Years(Adult)
性别
Female
接受健康志愿者

入选标准

  • American Society of Anesthesiologists physical status II parturients
  • Full term, singleton pregnancy
  • Elective cesarean delivery under spinal anesthesia

排除标准

  • Age <19 or > 40 years
  • Height <150 cm
  • Weight <60 kg
  • Body mass index ≥40 kg/m2
  • Contraindications to spinal anesthesia (increased intracranial pressure, coagulopathy, or local skin infection)
  • Chronic or pregnancy-induced hypertension
  • Hemoglobin <10 gm/dL.
  • Diabetes mellitus, cardiovascular, cerebrovascular, or renal disease
  • Polyhydramnios or known fetal abnormalities

研究组 & 干预措施

Combination

Experimental

500 mL colloid preload and 500 mL crystalloid coload. Cesarean delivery performed under spinal anesthesia (intrathecal bupivacaine 12.5 mg and intrathecal fentanyl 15 µg). Ultrasound assessment of the Inferior vena cava diameter. Intravenous ephedrine will be administered.

干预措施: 500 mL Colloid Preload (Drug)

Combination

Experimental

500 mL colloid preload and 500 mL crystalloid coload. Cesarean delivery performed under spinal anesthesia (intrathecal bupivacaine 12.5 mg and intrathecal fentanyl 15 µg). Ultrasound assessment of the Inferior vena cava diameter. Intravenous ephedrine will be administered.

干预措施: Spinal Anesthesia (Procedure)

Combination

Experimental

500 mL colloid preload and 500 mL crystalloid coload. Cesarean delivery performed under spinal anesthesia (intrathecal bupivacaine 12.5 mg and intrathecal fentanyl 15 µg). Ultrasound assessment of the Inferior vena cava diameter. Intravenous ephedrine will be administered.

干预措施: Intrathecal Bupivacaine (Drug)

Combination

Experimental

500 mL colloid preload and 500 mL crystalloid coload. Cesarean delivery performed under spinal anesthesia (intrathecal bupivacaine 12.5 mg and intrathecal fentanyl 15 µg). Ultrasound assessment of the Inferior vena cava diameter. Intravenous ephedrine will be administered.

干预措施: Intrathecal Fentanyl (Drug)

Combination

Experimental

500 mL colloid preload and 500 mL crystalloid coload. Cesarean delivery performed under spinal anesthesia (intrathecal bupivacaine 12.5 mg and intrathecal fentanyl 15 µg). Ultrasound assessment of the Inferior vena cava diameter. Intravenous ephedrine will be administered.

干预措施: 500 mL Crystalloid Coload (Drug)

Combination

Experimental

500 mL colloid preload and 500 mL crystalloid coload. Cesarean delivery performed under spinal anesthesia (intrathecal bupivacaine 12.5 mg and intrathecal fentanyl 15 µg). Ultrasound assessment of the Inferior vena cava diameter. Intravenous ephedrine will be administered.

干预措施: Cesarean Delivery (Procedure)

Combination

Experimental

500 mL colloid preload and 500 mL crystalloid coload. Cesarean delivery performed under spinal anesthesia (intrathecal bupivacaine 12.5 mg and intrathecal fentanyl 15 µg). Ultrasound assessment of the Inferior vena cava diameter. Intravenous ephedrine will be administered.

干预措施: Ultrasound Assessment of the Inferior Vena Cava (Radiation)

Combination

Experimental

500 mL colloid preload and 500 mL crystalloid coload. Cesarean delivery performed under spinal anesthesia (intrathecal bupivacaine 12.5 mg and intrathecal fentanyl 15 µg). Ultrasound assessment of the Inferior vena cava diameter. Intravenous ephedrine will be administered.

干预措施: Intravenous Ephedrine (Drug)

Coload

Active Comparator

1000 mL crystalloid coload. Cesarean delivery performed under spinal anesthesia (intrathecal bupivacaine 12.5 mg and intrathecal fentanyl 15 µg). Ultrasound assessment of the Inferior vena cava diameter. Intravenous ephedrine will be administered.

干预措施: Spinal Anesthesia (Procedure)

Coload

Active Comparator

1000 mL crystalloid coload. Cesarean delivery performed under spinal anesthesia (intrathecal bupivacaine 12.5 mg and intrathecal fentanyl 15 µg). Ultrasound assessment of the Inferior vena cava diameter. Intravenous ephedrine will be administered.

干预措施: Intrathecal Bupivacaine (Drug)

Coload

Active Comparator

1000 mL crystalloid coload. Cesarean delivery performed under spinal anesthesia (intrathecal bupivacaine 12.5 mg and intrathecal fentanyl 15 µg). Ultrasound assessment of the Inferior vena cava diameter. Intravenous ephedrine will be administered.

干预措施: Intrathecal Fentanyl (Drug)

Coload

Active Comparator

1000 mL crystalloid coload. Cesarean delivery performed under spinal anesthesia (intrathecal bupivacaine 12.5 mg and intrathecal fentanyl 15 µg). Ultrasound assessment of the Inferior vena cava diameter. Intravenous ephedrine will be administered.

干预措施: 1000 mL Crystalloid Coload (Drug)

Coload

Active Comparator

1000 mL crystalloid coload. Cesarean delivery performed under spinal anesthesia (intrathecal bupivacaine 12.5 mg and intrathecal fentanyl 15 µg). Ultrasound assessment of the Inferior vena cava diameter. Intravenous ephedrine will be administered.

干预措施: Cesarean Delivery (Procedure)

Coload

Active Comparator

1000 mL crystalloid coload. Cesarean delivery performed under spinal anesthesia (intrathecal bupivacaine 12.5 mg and intrathecal fentanyl 15 µg). Ultrasound assessment of the Inferior vena cava diameter. Intravenous ephedrine will be administered.

干预措施: Ultrasound Assessment of the Inferior Vena Cava (Radiation)

Coload

Active Comparator

1000 mL crystalloid coload. Cesarean delivery performed under spinal anesthesia (intrathecal bupivacaine 12.5 mg and intrathecal fentanyl 15 µg). Ultrasound assessment of the Inferior vena cava diameter. Intravenous ephedrine will be administered.

干预措施: Intravenous Ephedrine (Drug)

结局指标

主要结局

Total ephedrine dose

时间窗: intraoperative

次要结局

  • Incidence of severe hypotension(intraoperative)
  • Time to the first ephedrine dose(intraoperative)
  • Heart rate(intraoperative)
  • Inferior vena cava largest and smallest diameters(Baseline, at 1 and 5 minutes after intrathecal injection, delivery)
  • Inferior vena cava collapsibility index(Baseline, at 1 and 5 minutes after intrathecal injection, delivery)
  • Incidence of nausea and/or vomiting(intraoperative)
  • Neonatal Apgar score(At 1 and 5 minutes after delivery)
  • Incidence of hypotension(intraoperative)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Mohamed Mohamed Tawfik

Lecturer, Department of anesthesia and surgical intensive care, principal investigator

Mansoura University

研究点 (1)

Loading locations...

相似试验